New chemo cocktail shows promise for rare nasal cancer
NCT ID NCT00707473
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 37 times
Summary
This study tested a combination of three chemotherapy drugs (docetaxel, cisplatin, and fluorouracil) in 31 people with advanced nasal cavity or sinus cancer that had not been treated before. The goal was to shrink tumors and control the disease, while also tracking side effects and quality of life. The approach aims to reduce the need for more aggressive treatments like extensive surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINONASAL UNDIFFERENTIATED CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.